Key result
Low-dose aspirin prescribing for preeclampsia prevention was inconsistent or non-existent among practices serving 46,000 pregnant Medicaid beneficiaries, despite prevalent risk factors.
Why the study?
Pregnancy-related hypertensive disorders cause morbidity and mortality, and low-dose aspirin reduces risk, but clinical use and risk factor prevalence among Medicaid beneficiaries needed assessment.
What are the risk factors for preeclampsia and the clinical use of low-dose aspirin among pregnant Medicaid beneficiaries?
Observational (n=46,000)
Yes
What are the risk factors for preeclampsia and the clinical use of low-dose aspirin among pregnant Medicaid beneficiaries?
Answers are grounded in this paper and cite their sources.
There is a significant gap in the evidence-based prescription of low-dose aspirin for preeclampsia prevention among Medicaid beneficiaries, highlighting the need for clear policies and team education.
Pregnancy-related hypertensive disorders can cause morbidity and mortality. Low-dose aspirin (LDA) reduces risk. This paper aims to assess Medicaid beneficiaries' risk factors for preeclampsia and their providers' clinical use of LDA in the federal Strong Start for Mothers and Newborns II initiative. Twenty-seven awardees with more than 200 care sites served almost 46,000 women. This mixed-methods analysis assesses rates of risks, incidence of pregnancy-related hypertensive disorders, and assessment of care teams' LDA knowledge and reported prescription practices. Many Strong Start participants had risk factors that merited LDA, but most practices reported inconsistent or non-existent prescribing. Use varied within the three care models and among all provider types. Ancillary care team members often had no knowledge of LDA's benefits, resulting in lost opportunities for educating patients and assessing adherence to LDA use. Clear policies and well-integrated care teams could increase evidence-based use, improve pregnancy outcomes, and promote women's lifelong cardiovascular health.
No takes yet. Share an insight, caveat, or question.
Cross‐Barnet et al. (2020) conducted an observational in Preeclampsia risk (n=46,000). Low-dose aspirin (LDA) prescription practices was evaluated on Rates of risks, incidence of pregnancy-related hypertensive disorders, and care teams' LDA knowledge and prescription practices. Low-dose aspirin prescribing for preeclampsia prevention was inconsistent or non-existent among practices serving 46,000 pregnant Medicaid beneficiaries, despite prevalent risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: